COVID-19 and Solid Organ Transplantation: Role of Anti-SARS-CoV-2 Monoclonal Antibodies

PURPOSE OF REVIEW: Solid organ transplant recipients (SOTRs) are ideal candidates for early treatment or prevention of coronavirus disease 2019 (COVID-19) using anti-SARS-CoV-2 monoclonal antibodies because of multiple underlying medical conditions, chronic immune-suppression, sub-optimal immunogeni...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhand, Abhay, Razonable, Raymund R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
COVID-19 and Transplantation (R Avery, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760599/
https://www.ncbi.nlm.nih.gov/pubmed/35070639
http://dx.doi.org/10.1007/s40472-022-00357-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760599/
https://www.ncbi.nlm.nih.gov/pubmed/35070639
http://dx.doi.org/10.1007/s40472-022-00357-2

Ejemplares similares